Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain

Journal of Virology

Volumn 74, Issue 8, 2000, Pages 3537-3542

  Gundlach, Björn R ^a   Lewis, Mark G ^b   Sopper, Sieghart ^c   Schnell, Tanja ^a   Sodroski, Joseph ^d   Stahl Hennig, Christiane ^e   Überla, Klaus ^a,f  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e GERMAN PRIMATE CENTER   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACACA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS LOAD; VIRUS VIRULENCE;

ANIMALS; GENE PRODUCTS, ENV; GENE PRODUCTS, NEF; IMMUNIZATION; MACACA MULATTA; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, ATTENUATED; VIRAL LOAD; VIRULENCE;

EID: 0034124730     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.8.3537-3542.2000     Document Type: Article

References (32)

1. Almond, N. M., and J. L. Heeney. 1998. AIDS vaccine development in primate models. AIDS 12(Suppl. A):S133-S140.
2. Baba, T. W., Y. S. Jeong, D. Pennick, R. Bronson, M. F. Greene, and R. M. Ruprecht. 1995. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820-1825.
3. Baba, T. W., V. Liska, A. H. Khimani, N. B. Ray, P. J. Dailey, D. Penninck, R, Bronson, M. F. Greene, H. M. McClure. L. N. Martin, and R. M. Ruprecht. 1999. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med. 5:194-203.
4. Blatt, S. P., W. F. McCarthy, B. Bucko Krasnicka, G. P. Melcher, R. N. Boswell, J. Dolan, T. M. Freeman, J. M. Rusnak, R. E. Hensley, W. W. Ward, D. Barnes, and C. W. Hendrix. 1995. Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J. Infect. Dis. 171:837-844.
5. Bogers, W. M., H. Niphuis, P. ten Haaft, J. D. Laman, W. Koornstra, and J. L. Heeney. 1995. Protection from HIV-1 envelope-hearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge. AIDS 9:13-18.
6. Desrosiers, R. C. 1996. Live attenuated vaccines: best hope to prevent HIV? HIV Adv. Res. Ther. 3:3-9.
7. Dittmer, L., T. Nisslein, W. Bodemer, H. Petry, U. Sauermann, C. Stahl Hennig, and G. Hunsmann. 1995. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212:392-397.
8. Dolan, M. J., M. Clerici, S. P. Blatt, C. W. Hendrix, G. P. Melcher, R. N. Boswell, T. M. Freeman, W. Ward, R. Hensley, and G. M. Shearer. 1995. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus, J. Infect. Dis. 172:79-87.
9. Dunn, C. S., B. Hurtel, C. Beyer, L. Gloecker, T. N. Ledger, C. Moog, M. P. Kieny, M. Methali, D. Schmitt, J. P. Gut, A. Kirn, and A. M. Aubertin. 1997. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1. AIDS Res. Hum. Retrovir. 13:913-922.
10. Gundlach, B. R., H. Linhart, U. Dittmer, S. Sopper, S. Reiprich, D. Fuchs, B. Fleckenstein, G. Hunsmann, C. Stahl-Hennig, and K. Überla. 1997. Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2. J. Virol. 71:2225-2232.
11. Gundlach, B. R., S. Reiprich, S. Sopper, R. E. Means, U. Dittmer, K. Mätz-Rensing, C. Stahl-Hennig, and K. Überla. 1998. Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines. J. Virol. 72:7846-7851.
12. Hoch, J., S. M. Lang, M. Weeger, C. Stahl-Hennig, C. Coulibaly, U. Dittmer, G. Hunsmann, D. Fuchs, J. Müller, S. Sopper, B. Fleckenstein, and K. T. Überla. 1995. vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J. Virol. 69:4807-4813.
13. Johnson, R. P. 1999. Live attenuated AIDS vaccines: hazards and hopes. Nat. Med. 5:154-155.
14. Johnson, V., and R. E. Byington. 1990. Quantitative assays for virus infectivity, p. 71-76. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York, N.Y.
15. + lymphocyte decline in rhesus monkeys. J. Virol. 71:4218-4225.
16. Kestler, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
17. Kneitz, C., T. Kerkau, J. Müller, C. Coulibaly, C. Stahl-Hennig, G. Hunsmann, T. Hünig, and A. Schimpl. 1993. Early phenotypic and functional alterations in lymphocytes from simian immunodeficiency virus infected macaques. Vet. Immunol. lmmunopathol. 36:239-255.
18. Korber, B., B. Hahn, B. Foley, J. W. Mellors, T. Leitner, G. M. F. Myers, and C. L. Kuiken. 1997. Human retroviruses and AIDS 1997: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.Mex.
19. Lewis, M. G., J. Yalley-Ogunro, J. J. Greenhouse, T. P. Brennan, J. B. Jiang, T. C. VanCott, Y. Lu, G. A. Eddy, and D. L. Birx. 1999. Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus. J. Virol. 73:1262-1270.
20. Lohman, B. L., M. B. McChesney, C. J. Miller, E. McGowan, S. M. Joye, K. K. Van Rompay, E. Reay, L. Antipa, N. C. Pedersen, and M. L. Marthas. 1994. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68:7021-7029.
21. Miller, C. J., M. B. McChesney, X. Lü, P. J. Dailey, C. Chutkowski, D. Lu, P. Brosio, B. Roberts, and Y. Lu. 1997. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71:1911-1921.
22. Morphey-Corb, M., L. N. Martin, B. Davison-Fairburn, R. C. Montelaro, M. Miller, M. West, S. Ohkawa, G. Baskin, J.-Y. Zhang, S. D. Putney, A. C. Allison, and D. A. Eppstein. 1989. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246:1293-1297.
23. sm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res. Hum. Retrovir. 12:993-999.
24. Reimann, K. A., J. Li, R. Veazey, M. Halloran, I.-W. Park, G. B. Karlsson, J. Sodroski, and N, Letvin. 1996. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus isolate env causes AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70:6922-6928.
25. Shibata, R., C. Siemon, S. C. Czajak, R. C. Desrosiers, and M. A. Martin. 1997. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J. Virol. 71:8141-8148.
26. Stahl-Hennig, C., U. Dittmer, T. Nisslein, K. Pekrun, H. Petry, E. Jurkiewicz, D. Fuchs, H. Wachter, E. Rud, and G. Hunsmann. 1996. Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of nef deletion. Immunol. Today 51:129-135.
27. Überla, K., C. Stahl Hennig, D. Böttiger, K. Mätz-Rensing, F. J. Kaup, J. Li, W. A. Haseltine, B. Fleckenstein, G. Hunsmann, B. Öberg, and J. Sodroski. 1995. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. USA 92:8210-8214.
28. Whatmore, A. M., N. Cook, G. A. Hall, S. Sharpe, E. W. Rud, and M. P. Cranage. 1995. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J. Virol. 69:5117-5123.
29. Wooley, D. P., R. A. Smith, S. Czajak, and R. C. Desrosiers. 1997. Direct demonstration of retroviral recombination in a rhesus monkey. J. Virol. 71: 9650-9653.
30. Wyand, M. S., K. Manson, D. C. Montefiori, J. D. Lifson, R. P. Johnson, and R. C. Desrosiers. 1999. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J. Virol. 73:8356-8363.
31. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
32. Wyand, M. S., K. H. Manson, A. A. Lackner, and R. C. Desrosiers. 1997. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nat. Med. 3:32-36.